Empagliflozin
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Caroline M Kistorp
Overview
Empagliflozin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Empagliflozin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Empagliflozin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.